8 Stocks Roaring Higher on Unusual Volume
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.
With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.
Amicus Therapeutics (FOLD)
This is a clinical-stage biopharmaceutical company is focused on the discovery, development and commercialization of a new class of orally-administered, small molecule drugs, for the treatment of a range of human genetic diseases. This stock is trading up 4.4% to $2.64 in recent trading.
Today's Range: $2.47-$2.68
52-Week Range: $2.52-$7.29
Volume: 2.64 million
Three-Month Average Volume: 867,526
From a technical perspective, FOLD is bouncing higher here right off its 52-week low of $2.47 with heavy upside volume. This bounce is coming after FOLD gapped down big last week from over $5.75 to under $3.25 with heavy downside volume. Following that gap, shares of FOLD continued lower below $3 with above-average volume flows. That move has pushed FOLD into oversold territory, since its relative strength index (RSI) reading is now 23.99. Oversold can always get more oversold, but it's also an area where a stock can see a sharp bounce from.
Traders should now look for long-biased trades in FOLD as long as it's trending above its 52-week low of $2.47, and then once it sustains a move or close above some near-term overhead resistance at $2.75 with volume that hits near or above 867,526 shares. If that breakout hits soon, then FOLD will set up to re-test or possibly take out its next major overhead resistance levels at $3 to its gap down day high of $3.43.
Regulus Therapeutics (RGLS)
This is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a broad range of diseases. This stock is trading up 12% to $5.81 in recent trading.